GlassScriptPhysician profile
Paul A Whitham
NPI 1437137122
$1,228.99
in general payments reported to CMS, 2019-2025
14 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $27.56 · 2021: $258 · 2022: $143 · 2023: $231 · 2024: $149 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $285.32 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $247.61 | 2022-2025 | |
| Conmed Corporation | $152.49 | 2022-2024 | Airseal |
| Abbvie INC. | $148.59 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Bayer Healthcare Pharmaceuticals INC. | $79.50 | 2019-2025 | |
| Shield Therapeutics INC | $55.75 | 2025 | |
| Ethicon US, LLC | $54.44 | 2025 | Stratafix |
| Agile Therapeutics, INC. | $54.04 | 2023-2024 | Twirla |
| Astellas Pharma US INC | $48.09 | 2025 | Veozah |
| Meditrina | $33.57 | 2023-2025 | |
| Hologic Sales and Service, LLC | $26.21 | 2024 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Mallinckrodt Enterprises LLC | $17.76 | 2019 | |
| Exact Sciences Corporation | $14.20 | 2023 | Cologuard Collection Kit |
| Allergan, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Whitham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.